FTO Regulates Porcine Adipogenesis and Postnatal Survival of Cloned Embryos.
Wang X., Zhang M., Yang Z., Hu K., Zhu R., Yue Y.
Animal Study, published in FASEB J (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- FASEB J (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42257483
- DOI
- 10.1096/fj.202504686RR
Abstract (original English)
The fat mass and obesity-associated gene (FTO), the first obesity-related gene and m6A demethylase, has well-defined roles in rodents but remains poorly understood in large mammals. Here, we combined siRNA-mediated knockdown, transcriptome sequencing, and bioinformatics to explore FTO function in porcine adipogenesis and embryo development. FTO silencing inhibited cell proliferation, promoted apoptosis, and suppressed adipogenic differentiation of adipose-derived mesenchymal stem cells (ADSCs) by downregulating key adipogenic genes (PPARγ, C/EBPα, FABP4, SCD, ACCα, LPL). Transcriptome analysis of CRISPR/Cas9-generated FTO-knockout fetal fibroblasts revealed altered pathways related to the cell cycle, senescence, apoptosis, and metabolism, including PI3K-Akt, Wnt, MAPK, and Apelin signaling. Using these knockout cells for somatic cell nuclear transfer (SCNT), we found that while FTO loss did not affect blastocyst formation, all cloned piglets carrying the mutation died postnatally. These results demonstrate that FTO is essential for porcine adipogenesis and postnatal survival of cloned embryos. The findings provided a new insight into the roles and mechanisms of FTO in fat metabolism and development in large mammals.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.